Literature DB >> 31809781

Economics and ecology: Modelling of continuous primary recovery and capture scenarios for recombinant antibody production.

A L Cataldo1, D Burgstaller1, G Hribar2, A Jungbauer3, P Satzer4.   

Abstract

With the maturation of antibody production technologies, both economic optimization and ecological aspects have become important. Continuous downstream processing is a way to reduce the environmental footprint and improve process economics. We compared different primary recovery, capture, and fermentation methods for two output-based antibody production scales: 50 kg/year and 1000 kg/year. In addition, a fixed fermentation volume case of 1000 L was analysed in terms of total cost of goods and process mass intensity as a measure of the environmental footprint. In our scenario, a significant amount of water can be saved in downstream processing when single use equipment is utilized. The overall economic and ecological impact is governed by the product titre in our perfusion (1 g/L) and fed-batch (4 g/L). A low titre in fermentation with similar downstream purification leads to higher process mass intensity and cost of goods due to the higher media demand upstream. The economic perspective for continuous integrated biomanufacturing is very attractive, but environmental consequences should not be neglected. Here, we have shown that perfusion has a higher environmental footprint in the form of water consumption compared to fed-batch. As general guidance to improve process economics, we recommend reducing water consumption.
Copyright © 2019 Elsevier B.V. All rights reserved.

Keywords:  BioSolve; Continuous bioprocessing; Cost of goods; Footprint; Perfusion cell culture; Process mass intensity

Mesh:

Substances:

Year:  2019        PMID: 31809781     DOI: 10.1016/j.jbiotec.2019.12.001

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  4 in total

Review 1.  A common framework for integrated and continuous biomanufacturing.

Authors:  Jonathan Coffman; Mark Brower; Lisa Connell-Crowley; Sevda Deldari; Suzanne S Farid; Brian Horowski; Ujwal Patil; David Pollard; Maen Qadan; Steven Rose; Eugene Schaefer; Joseph Shultz
Journal:  Biotechnol Bioeng       Date:  2021-03-01       Impact factor: 4.530

Review 2.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

3.  Media on-demand: Continuous reconstitution of a chemically defined media directly from solids.

Authors:  Daniel Komuczki; Gregory Dutra; Christoph Gstöttner; Elena Dominguez-Vega; Alois Jungbauer; Peter Satzer
Journal:  Biotechnol Bioeng       Date:  2021-03-25       Impact factor: 4.530

4.  Continuous countercurrent chromatographic twin-column purification of oligonucleotides: The role of the displacement effect.

Authors:  Ismaele Fioretti; Thomas Müller-Späth; Richard Weldon; Sebastian Vogg; Massimo Morbidelli; Mattia Sponchioni
Journal:  Biotechnol Bioeng       Date:  2022-04-06       Impact factor: 4.395

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.